Use of thiazolidinedione and cancer risk in Type 2 diabetes: The Hong Kong diabetes registry

Autor:	Xilin Yang, Risa Ozaki, Gary T.C. Ko, Linda W.L. Yu, Alice P.S. Kong, Ronald C.W. Ma, Heung Man Lee, Gang Xu, Juliana C.N. Chan, Wing-Yee So
Rok vydání:	2012
Předmět:	Male Oncology medicine.medical_specialty Reduced risk endocrine system diseases medicine.drug_class Endocrinology Diabetes and Metabolism Type 2 diabetes Endocrinology Asian People Predictive Value of Tests Neoplasms Diabetes mellitus Internal medicine Internal Medicine medicine Humans Hypoglycemic Agents Registries Thiazolidinedione Aged Dose-Response Relationship Drug business.industry Cancer General Medicine Middle Aged medicine.disease Metformin Surgery Diabetes Mellitus Type 2 Hong Kong Female Thiazolidinediones Cancer risk business Follow-Up Studies
Zdroj:	Diabetes Research and Clinical Practice. 97:e13-e17
ISSN:	0168-8227
Popis:	We examined possible anticancer effects of thiazolidinediones (TZDs) in 6074 Chinese with Type 2 diabetes free of cancer at enrolment. During a median follow-up of 4.93 years, 270 patients developed cancer. Use of TZDs was associated with reduced risk of cancer in a dose–response manner in multivariable analysis.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f631470cb20791534ee8f7291c16bbb https://doi.org/10.1016/j.diabres.2012.03.006 Zobrazit plný text záznamu Full Text from ScienceDirect